The Costs of Schizophrenia.
J Clin Psychiatry 2007;68(suppl 14):4-7
© Copyright 2017 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Reasonably accurate approximations of the financial costs of schizophrenia
are the foundation for making judgments about the socioeconomic impact of the
disorder and the cost-effectiveness of treatment modalities. The financial
costs of schizophrenia to society can be divided into direct and indirect
costs. Direct costs include treatment provided in inpatient, outpatient, and
long-term care, as well as criminal justice costs, medication costs, and
publicly owned capital such as state mental health facilities. Indirect costs
mostly arise from the productivity loss suffered by individuals with
schizophrenia, family members, and caregivers. The cost of schizophrenia in
the United States in 2002 was estimated to be $62.7 billion. Compared with a
1991 estimate, inpatient costs have declined, whereas outpatient costs and
medication costs have increased. When interpreting any data regarding costs,
people should be aware of factors that influence results, such as the
perspective from which the analysis was undertaken, the measures used in the
analysis, and planned or unplanned bias.